London will be home to a drug manufacturer’s world headquarters.
Anvo Laboratories, now a drug distributor in Oakville, will open a pharmaceutical business making generic drugs here in London.
Anvo has purchased 3.6 hectares of land in the city’s Advanced Manufacturing Park and will employ about 30 when it begins production in 2022.
“Post-COVID, it will be important for London to build capacity in the health-care sector, to ramp up in health care,” said Kapil Lakhotia, Chief Executive of the London Economic Development Corp., which worked with Anvo to bring them to London.
Anvo is already planning the second and third phases of construction and growth if the market demands it.
